Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Sbalchiero

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Internal and Emergency Medicine|February 5, 2026
Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profileValeria Caggiano, Antonio Vitale, Jessica Sbalchiero, et al.
Ophthalmology and Therapy|March 25, 2026
Irreversible Ocular and Systemic Damage in ROSAH SyndromeClaudia Fabiani, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|October 2, 2024
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis RegistryAntonio Vitale, Valeria Caggiano, Eduardo Martín-Nares, et al.
Frontiers in Medicine|September 19, 2025
Development and implementation of the International AIDA Network Castleman's disease registryAntonio Vitale, Jessica Sbalchiero, Valeria Caggiano, et al.
Clinical and Experimental Rheumatology|October 24, 2025
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Ophthalmology and Therapy|May 9, 2026
Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis RegistryJurgen Sota, Andrea Hinojosa-Azaola, Alejandra de-la-Torre, et al.
Ophthalmology and Therapy|September 22, 2025
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis RegistryCarla Gaggiano, Alejandra De-la-Torre, Juanita Cardona-López, et al.
American Journal of Ophthalmology|November 16, 2025
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis RegistryCarla Gaggiano, Alejandra DE-LA-Torre, Silvana Guerriero, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Internal and Emergency Medicine|February 5, 2026
Dual targeted therapy with biologic agents and small molecules in refractory inflammatory arthritis: clinical outcomes and safety profileValeria Caggiano, Antonio Vitale, Jessica Sbalchiero, et al.
Ophthalmology and Therapy|March 25, 2026
Irreversible Ocular and Systemic Damage in ROSAH SyndromeClaudia Fabiani, Valeria Caggiano, Jessica Sbalchiero, et al.
Frontiers in Medicine|October 2, 2024
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis RegistryAntonio Vitale, Valeria Caggiano, Eduardo Martín-Nares, et al.
Frontiers in Medicine|September 19, 2025
Development and implementation of the International AIDA Network Castleman's disease registryAntonio Vitale, Jessica Sbalchiero, Valeria Caggiano, et al.
Clinical and Experimental Rheumatology|October 24, 2025
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|May 8, 2026
Correction to: IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler RegistryLaura Calabrese, Alessandra Cartocci, Antonio Vitale, et al.
Ophthalmology and Therapy|May 9, 2026
Determinants of Non-infectious Scleritis Complications and Their Impact on Visual Outcome: Results from the International AIDA Network Scleritis RegistryJurgen Sota, Andrea Hinojosa-Azaola, Alejandra de-la-Torre, et al.
Ophthalmology and Therapy|September 22, 2025
Incidence and Predictors of Ocular Complications in Pediatric-Onset Uveitis: Data from the AIDA Network Uveitis RegistryCarla Gaggiano, Alejandra De-la-Torre, Juanita Cardona-López, et al.
American Journal of Ophthalmology|November 16, 2025
Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity: Data From the AIDA Network Uveitis RegistryCarla Gaggiano, Alejandra DE-LA-Torre, Silvana Guerriero, et al.
Frontiers in Immunology|March 30, 2026
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA NetworkValeria Caggiano, Jessica Sbalchiero, Micol Frassi, et al.
Pageof 3